Oleg Gavrilyuk, MD
Physical Medicine & Rehabilitation · San Diego, CANPI 1952496291
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.9% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,657 and has fallen 83.5% since, to $602 in 2025. Among physical medicine & rehabilitation clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 263 payments — averaging $36.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Amgen$2K
- Scilex Pharmaceuticals Inc.$1K
- Medical Device Business Services, Inc.$680
- Radius Health, Inc.$484
- AbbVie$420
- plus $3K from 32 others
What the payments were for
- Consulting fees$6807%
- Food & beverage$8,94293%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 33 | $2,310 |
| Amgen(2 entities) | 59 | $1,565 |
| Scilex Pharmaceuticals Inc. | 67 | $1,167 |
| Medical Device Business Services, Inc. | 1 | $680 |
| Radius Health, Inc. | 14 | $484 |
| AbbVie(2 entities) | 7 | $420 |
| Johnson & Johnson(2 entities) | 7 | $382 |
| Collegium Pharmaceutical, Inc. | 14 | $292 |
| Bioventus LLC | 12 | $290 |
| Pacira Therapeutics, Inc. | 3 | $255 |
| AstraZeneca(2 entities) | 2 | $249 |
| Teva Pharmaceuticals USA, Inc. | 3 | $245 |
| Si-bone, Inc. | 1 | $173 |
| Novo Nordisk | 2 | $144 |
| Kyowa Kirin, Inc. | 2 | $131 |
| Pfizer | 1 | $121 |
| Kowa Pharmaceuticals America, Inc. | 6 | $110 |
| IBSA Pharma Inc. | 4 | $74 |
| Edwards Lifesciences | 1 | $52 |
| UCB, Inc. | 2 | $47 |
| Abbott | 2 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Jazz Pharmaceuticals Inc. | 1 | $37 |
| Avanos Medical | 2 | $36 |
| Livanova USA, Inc. | 2 | $34 |
| Novartis | 1 | $25 |
| CSL Behring | 1 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Zimmer Biomet | 1 | $19 |
| Neurelis, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Medline Industries LP | 1 | $16 |
| Fidia Pharma USA Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,630 in reported general payments places this provider in the 90th percentile of 830 physical medicine & rehabilitation providers in California.
See all physical medicine & rehabilitation providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProliaDenosumab | 22 | $36,614 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 14 | $33,675 |
| NucyntaTapentadol Hcl | 22 | $21,505 |
| ZtlidoLidocaine | 28 | $11,586 |
| LicartDiclofenac Epolamine | 13 | $9,213 |
| LyricaPregabalin | 24 | $7,060 |
| TradjentaLinagliptin | 11 | $5,164 |
| Buprenorphine | 15 | $4,770 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 152 | $4,127 |
| Pregabalin | 147 | $2,280 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 108 | $1,780 |
| Lidocaine | 20 | $1,597 |
| Diclofenac Sodium | 56 | $1,570 |
| Gabapentin | 98 | $986 |
| Etodolac | 29 | $760 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia, Evenity (2 Syringes) | $1,565 | $70,28936 claims |
| Collegium Pharmaceutical, Inc.Nucynta | $292 | $21,50522 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $1,167 | $11,58628 claims |
| IBSA Pharma Inc.Licart | $74 | $9,21313 claims |
| PfizerLyrica | $121 | $7,06024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 830 physical medicine & rehabilitation providers in California.
Other physical medicine & rehabilitation in San Diego
- Jeffrey ChenSan Diego$59K
- Kyle RyanSan Diego$39K
- Andrew SkalskySan Diego$16K
- Rajiv ReddySan Diego$13K
- Jeffry MercadoSan Diego$9K
- Ziyad AyyoubParamount$322K
- Pratik GandhiAnaheim$122K
- Mary OatesSanta Maria$115K
- Kevin BarretteSan Francisco$84K
- Steven SampsonLos Angeles$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.